Clinical Trials · NCT06318442
The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- Imperial College London
- Enrollment
- 60
- Start date
- May 2024
- Locations
- 1 site, United Kingdom
- Primary endpoint
- Difference in Glucose tolerance